Search research articles
Contact Us
Filters
Showing results (111-120 of 141) with videos related to
Page
of 15
Sort By:
Cancer Research
|
March 9, 2021
Genomic Alterations in <i>PIK3CA</i>-Mutated Breast Cancer Result in mTORC1 Activation and Limit the Sensitivity to PI3Kα Inhibitors
Yanyan Cai, Guotai Xu, Fan Wu, et al.
The Lancet. Oncology
|
June 21, 2015
Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial
Sara A Hurvitz, Fabrice Andre, Zefei Jiang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 17, 2023
Impact of pembrolizumab versus chemotherapy on health-related quality of life in patients with metastatic triple-negative breast cancer: results from the phase 3 randomised KEYNOTE-119 study
Peter Schmid, Oleg Lipatov, Seock-Ah Im, et al.
ESMO Open
|
November 11, 2020
Body weight and return to work among survivors of early-stage breast cancer
Antonio Di Meglio, Gwenn Menvielle, Agnes Dumas, et al.
Cell Death & Disease
|
June 10, 2021
Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index
Adrien Joseph, Hui Chen, Gerasimos Anagnostopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 17, 2019
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
Sherene Loi, Damien Drubay, Sylvia Adams, et al.
Genome Medicine
|
August 13, 2010
Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasets
Charles Swanton, James M Larkin, Marco Gerlinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2019
Lucitanib for the Treatment of HR<sup>+</sup>/HER2<sup>-</sup> Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE Study
Rina Hui, Alex Pearson, Javier Cortes, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 2016
Factors associated with success of image-guided tumour biopsies: Results from a prospective molecular triage study (MOSCATO-01)
Vania Tacher, Marie-Cécile Le Deley, Antoine Hollebecque, et al.
JCO Precision Oncology
|
December 8, 2022
Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care
Edwin Cuppen, Olivier Elemento, Richard Rosenquist, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 141) with videos related to
Sort By:
Page
of 15
Cancer Research
|
March 9, 2021
Genomic Alterations in <i>PIK3CA</i>-Mutated Breast Cancer Result in mTORC1 Activation and Limit the Sensitivity to PI3Kα Inhibitors
Yanyan Cai, Guotai Xu, Fan Wu, et al.
The Lancet. Oncology
|
June 21, 2015
Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial
Sara A Hurvitz, Fabrice Andre, Zefei Jiang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 17, 2023
Impact of pembrolizumab versus chemotherapy on health-related quality of life in patients with metastatic triple-negative breast cancer: results from the phase 3 randomised KEYNOTE-119 study
Peter Schmid, Oleg Lipatov, Seock-Ah Im, et al.
ESMO Open
|
November 11, 2020
Body weight and return to work among survivors of early-stage breast cancer
Antonio Di Meglio, Gwenn Menvielle, Agnes Dumas, et al.
Cell Death & Disease
|
June 10, 2021
Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index
Adrien Joseph, Hui Chen, Gerasimos Anagnostopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 17, 2019
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
Sherene Loi, Damien Drubay, Sylvia Adams, et al.
Genome Medicine
|
August 13, 2010
Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasets
Charles Swanton, James M Larkin, Marco Gerlinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2019
Lucitanib for the Treatment of HR<sup>+</sup>/HER2<sup>-</sup> Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE Study
Rina Hui, Alex Pearson, Javier Cortes, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 2016
Factors associated with success of image-guided tumour biopsies: Results from a prospective molecular triage study (MOSCATO-01)
Vania Tacher, Marie-Cécile Le Deley, Antoine Hollebecque, et al.
JCO Precision Oncology
|
December 8, 2022
Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care
Edwin Cuppen, Olivier Elemento, Richard Rosenquist, et al.
Page
of 15